Clinical trial
A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors
NCT00006036 is registered in ClinicalTrials.gov with NCIC Clinical Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of NX 211 in Combination With Cisplatin Given as an IV Infusion Days 1, 2, and 3 Every 3 Weeks in Patients With Solid Tumors
- Lead sponsor
- NCIC Clinical Trials Group
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 22, 2000
- Completion date
- December 21, 2009
- Enrollment
- 14 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer, lung cancer, ovarian cancer, unspecified adult solid tumor, protocol specific